[{"Assets_0_Q3_USD":265812000.0,"CommonStockSharesOutstanding_0_Q3_shares":44108407.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-72653000.0,"NetIncomeLoss_1_Q3_USD":-41409000.0,"NetIncomeLoss_3_Q3_USD":-114103000.0,"StockholdersEquity_0_Q3_USD":151281000.0,"Ticker":"RVNC","CIK":"1479290","name":"REVANCE THERAPEUTICS, INC.","OfficialName":"Revance Therapeutics Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1265045755.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191104"}]